BioCentury
ARTICLE | Clinical News

Tobramycin inhalation powder regulatory update

March 25, 2013 7:00 AM UTC

FDA approved an NDA from Novartis for TOBI Podhaler to manage cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. TOBI Podhaler, which uses a disposable inhaler device to delive...